Local Infiltration Analgesia for Hip Arthroscopy
Effectiveness of Ultrasound Guided Hip Infiltration With Local Anesthetic Solution for Pain Control After Hip Arthroscopy
1 other identifier
interventional
36
1 country
1
Brief Summary
The purpose of this study is to examine if ultrasound guided infiltration of local anesthetic solution around the hip joint will provide effective pain control after hip arthroscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable pain
Started Oct 2011
Typical duration for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 6, 2011
CompletedFirst Posted
Study publicly available on registry
October 19, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedMarch 11, 2013
March 1, 2013
11 months
October 6, 2011
March 8, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post operative opioid consumption.
Amount in milligrams of opioid consumption post surgery in the recovery room and for a 24 hour period.
Within 24 hours after surgery
Secondary Outcomes (1)
Pain scores in recovery room.
Within 24 hours of the surgery
Study Arms (2)
Infiltration of local anesthetic
EXPERIMENTAL30 ml of ropivacaine 0.5% infiltrated around lateral anterior and medial aspect of hip joint with ultrasound guidance.
Normal Saline Injection
PLACEBO COMPARATORinjection of 30ml normal saline infiltrated around lateral anterior and medial aspect of hip joint with ultrasound guidance.
Interventions
30 ml of ropivacaine 0.5% infiltrated around lateral anterior and medial aspect of hip joint with ultrasound guidance.
injection of 30ml normal saline infiltrated around lateral anterior and medial aspect of hip joint with ultrasound guidance.
Eligibility Criteria
You may qualify if:
- hip arthroscopy
- ages 18-80
You may not qualify if:
- history of neurological disease
- diabetes
- pregnancy
- neuropathy
- chronic narcotic use
- allergy to local anesthetic solution
- inability to give consent or cooperate with the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saint Francis Hospital and Medical Center
Hartford, Connecticut, 06105, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sanjay Sinha, M.D.
Saint Francis Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 6, 2011
First Posted
October 19, 2011
Study Start
October 1, 2011
Primary Completion
September 1, 2012
Study Completion
February 1, 2013
Last Updated
March 11, 2013
Record last verified: 2013-03